Suppr超能文献

微小RNA 141通过抑制BMI1来抑制鼻咽癌的生长。

MicroRNA 141 represses nasopharyngeal carcinoma growth through inhibiting BMI1.

作者信息

Liu Fei, Wang Wenjuan, Li Shuo, Yang Qiong, Hu Jing, Zeng Nan, Gao Chunsheng

机构信息

Department of Otolaryngology, Nanshan Affiliated Hospital of Guangdong Medical College, Shenzhen, Guangdong 518052, P.R. China.

出版信息

Oncol Lett. 2018 Nov;16(5):6479-6487. doi: 10.3892/ol.2018.9444. Epub 2018 Sep 18.

Abstract

Distant metastasis is the primary cause of mortality in patients with nasopharyngeal carcinoma (NPC). Unveiling the mechanism of metastasis will aid in shedding light on the clinical therapeutic strategies in NPC treatment. The present study revealed that the expression of microRNA 141 (miR-141) was downregulated in NPC tumor cells, particularly in metastatic ones. Ectopic expression of miR-141 blocked the proliferative and invasive ability of the tumor cells , and inhibited NPC tumor growth . Mechanistic studies identified that BMI1 served as the direct target of miR-141, and overexpression of BMI1 reversed the tumor repressor effect of miR-141. Prognostic analysis revealed that this miR-141/BMI1 signaling axis correlated with the clinical stage of patients with NPC. The study of miR-141 provided novel insight into the mechanism of NPC progression, which was correlated with the stage and metastatic state of patients. This miR-141/BMI1 axis may serve as a novel pharmacological target in NPC treatment.

摘要

远处转移是鼻咽癌(NPC)患者死亡的主要原因。揭示转移机制将有助于阐明鼻咽癌治疗的临床治疗策略。本研究表明,微小RNA 141(miR-141)在NPC肿瘤细胞中表达下调,尤其是在转移性肿瘤细胞中。miR-141的异位表达阻断了肿瘤细胞的增殖和侵袭能力,并抑制了NPC肿瘤生长。机制研究确定BMI1是miR-141的直接靶点,BMI1的过表达逆转了miR-141的肿瘤抑制作用。预后分析表明,该miR-141/BMI1信号轴与NPC患者的临床分期相关。对miR-141的研究为NPC进展机制提供了新的见解,这与患者的分期和转移状态相关。该miR-141/BMI1轴可能作为NPC治疗的新的药理学靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be74/6202537/3adccd007593/ol-16-05-6479-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验